Canopy Growth (CGC) Change in Receivables (2019 - 2026)
Canopy Growth (CGC) posted Change in Receivables of -$14.1 million for Q4 2025, down 568.28% sequentially from -$2.1 million in Q2 2025, and down 378.38% YoY from $5.1 million in Q4 2024.
Canopy Growth (CGC) Change in Receivables (2019 - 2026) Analysis & Trends
Canopy Growth has reported Change in Receivables for 7 years, with the latest figure at -$14.1 million in Q4 2025.
- Quarterly Change in Receivables fell 378.38% year-over-year to -$14.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$13.5 million (down 134.36% YoY) and the FY2026 annual result came in at -$18.7 million, down 699.22% from the prior year.
- Change in Receivables retreated to -$14.1 million in Q4 2025 per CGC's latest filing, from -$2.1 million in the prior quarter.
- Over five years, Change in Receivables peaked at $15.2 million in Q2 2023 and troughed at -$14.1 million in Q4 2025.
- A 5-year average of -$1.6 million and a median of -$1.4 million in 2025 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2023: Change in Receivables tumbled 2250.97% in 2022, then surged 612.35% in 2023.
- Over 5 years, Change in Receivables stood at $6.6 million in 2021, then tumbled by 111.71% to -$768381.2 in 2022, then soared by 248.84% to $1.1 million in 2023, then jumped by 341.59% to $5.1 million in 2024, then sank by 378.38% to -$14.1 million in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered -$14.1 million, -$2.1 million, and $5.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn | 4.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.43 Mn |
| Jun 30, 2026 | 4.43 Mn |
| Dec 31, 2025 | -14.06 Mn |
| Dec 31, 2025 | -14.06 Mn |
| Jun 30, 2025 | -2.10 Mn |
| Jun 30, 2025 | -2.10 Mn |
| Dec 31, 2024 | 5.05 Mn |
| Dec 31, 2024 | 5.05 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -488,401.89 |
| Jun 30, 2024 | -488,401.89 |
| Mar 31, 2024 | -7.95 Mn |
| Mar 31, 2024 | -7.95 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | -5.60 Mn |
| Sep 30, 2023 | -5.60 Mn |
| Jun 30, 2023 | 15.19 Mn |
| Jun 30, 2023 | 15.19 Mn |